Hedström, Anna Karin
Huang, Jesse
Brenner, Nicole
Butt, Julia
Hillert, Jan
Waterboer, Tim
Kockum, Ingrid
Olsson, Tomas
Alfredsson, Lars
Funding for this research was provided by:
Svenska Sällskapet för Medicinsk Forskning
EC | Horizon 2020 Framework Programme
Vetenskapsrådet
Hjärnfonden
Article History
Received: 18 November 2019
Accepted: 29 May 2020
First Online: 3 July 2020
Competing interests
: Hedström, Huang, Brenner, Butt, and Waterboer report no disclosures. Kockum received speaker's fees from Merck-Serono, and is involved in a project sponsored by Biogen. Hillert received honoraria for serving on advisory boards for Biogen and Novartis and speaker’s fees from Biogen, Merck-Serono, Bayer-Schering, Teva and Sanofi-Aventis. He has served as principal investigator for projects sponsored by, or received unrestricted research support from, Biogen, Merck-Serono, TEVA, Novartis and Bayer-Schering. TO served on scientific advisory boards and received speaker honoraria Novartis, Merck-Serono, Biogen Idec, TEVA and Genzyme; served as Co-editor of Current Opinion in Immunology; received from Novartis and Biogen; and receives research support from Novartis, Genzyme, Biogen Idec, the Swedish Research Council (07488), EU fp7 Neurinox, and CombiMS, and the Swedish Brain Foundation. Alfredsson received research support from the Swedish Medical Research Council (Dnr 2016-02349), the Swedish Council for Health, Working Life and Welfare (Dnr 2015-00195) and the Swedish Brain Foundation; has received speaker honoraria from Biogen Idec and TEVA.